Open Orphan #ORPH – Directorate Change

  Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces the appointment of Yamin ‘Mo’ Khan as an Independent Non-Executive Director to the Board of Open Orphan with immediate effect. Mo will also Chair both the Audit and Risk and […]

Open Orphan #ORPH – Controlled Human Infection Studies Report following March Webinar

Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain.   Report follows March Webinar run by hVIVO with HIC VAC, Wellcome Trust and IABS Highlights: Applicable local, national and regional guidelines on manufacture and use of challenge agents must be considered. As challenge agents are biological products, […]